1998
DOI: 10.1097/00000374-199811000-00028
|View full text |Cite
|
Sign up to set email alerts
|

Carbohydrate-Deficient Transferrin

Abstract: We tested the diagnostic validity of carbohydrate-deficient transferrin (CDT) as an indicator for relapse into elevated alcohol consumption among patients who were examined under follow-up treatment before (n = 147) and after (n = 102) orthotopic liver transplantation (OLT) in the outpatient-department of the University Hospital Department of Surgery in Hamburg-Eppendorf. CDT measurements were performed with two commercial kits in parallel (CDTect-RIA and CDT%-RIA). Short-term parameters of alcohol consumption… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 35 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Of note, our lab rarely sees this pattern in populations where liver disease has been vigorously excluded (e.g., clinical trial subjects), but frequently in patients whose samples come from liver clinics and acute care hospitals. In testing for heavy drinking, di-tri bridging could lead to false positive results for alcohol use if not interpreted correctly, and this phenomenon may underlie prior findings on low specificity of alternative CDT immunoassays for heavy drinking among liver disease patients (DiMartini et al, 2001; Heinemann et al, 1998). However, as the HPLC assay enables detection of this effect, proper interpretation will minimize false positive results associated with liver disorders.…”
Section: Discussionmentioning
confidence: 99%
“…Of note, our lab rarely sees this pattern in populations where liver disease has been vigorously excluded (e.g., clinical trial subjects), but frequently in patients whose samples come from liver clinics and acute care hospitals. In testing for heavy drinking, di-tri bridging could lead to false positive results for alcohol use if not interpreted correctly, and this phenomenon may underlie prior findings on low specificity of alternative CDT immunoassays for heavy drinking among liver disease patients (DiMartini et al, 2001; Heinemann et al, 1998). However, as the HPLC assay enables detection of this effect, proper interpretation will minimize false positive results associated with liver disorders.…”
Section: Discussionmentioning
confidence: 99%
“…This group of Tf isoforms is referred to as the carbohydrate-deficient Tf's (CDT) and the correlation of their increased levels with chronic alcoholism has been reported to be the most specific biomarker for this condition [89][90][91]. However, other conditions such as inherited forms of glycoprotein metabolism (carbohydrate-deficient glycoprotein (CDG) syndrome) [92,93], the existence of rare Tf isoforms [94,95], and certain end-stage liver diseases may also result in increased CDT [96]. It is also important to note that several studies have found that increases in CDT are less pronounced in females with long-term alcohol consumption [97,98].…”
Section: Carbohydrate-deficient Transferrins (Tf's)mentioning
confidence: 99%
“…These provide a single value for the collective CDT level (CDT defined as di-, mono-, asialo-and, in some cases, 50% of trisialo-Tf), but fail to define the relative concentrations of the individual Tf sialoforms which may bear clinically relevant information [16,17]. Separation and quantitation using anion exchange columns is better suited to routine analyses; however, recovery of the CDT sialoforms (< 30 mg/L) in a primarily non-CDT matrix (approximately 3000 mg/L) is crucial for accurate results [18].…”
Section: Introductionmentioning
confidence: 99%